Communiqués Nuo Therapeutics, Inc.

Actions

AURX

US67059V2097

Temps Différé OTC Markets Autres places de cotation 18:47:57 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,384 ^USD	-1,54%		+2,05%	-30,18%

15/05	Nuo Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
19/04	Nuo Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	26/06/23	AQ
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	22/06/23	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	17/04/23	AQ
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	05/12/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	04/11/22	AQ
NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)	30/09/22	AQ
Nuo Therapeutics Provides Corporate and Business Update	30/08/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	30/08/22	AQ
Nuo Therapeutics : Amendment to Quarterly Report - Form 10-Q/A	10/08/22	PU
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	10/08/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	08/08/22	AQ
NUO THERAPEUTICS, INC. : Other Events (form 8-K)	28/06/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/05/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/05/22	AQ
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/04/22	AQ
Nuo Therapeutics Responds to Mini-Tender Offer	04/02/22	GL
Alternative Liquidity Index Announces Offer to Purchase Shares in Nuo Therapeutics, Inc.	21/01/22	AQ
NUO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	04/01/22	AQ
NUO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21/04/21	AQ
Nuo Therapeutics : Announces Publication of Final Decision Memo for Autologous Blood Derived Products for Chronic Non-Healing Wounds by Centers for Medicare & Medicaid Services	20/04/21	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Nuo Therapeutics, Inc.

Actions

AURX

US67059V2097

Communiqués

Filtres